Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CCR5 and CCL5 gene expression in colorectal cancer: comprehensive profiling and clinical value.
Battaglin F, Baca Y, Millstein J, Yang Y, Xiu J, Arai H, Wang J, Ou FS, Innocenti F, Mumenthaler SM, Jayachandran P, Kawanishi N, Lenz A, Soni S, Algaze S, Zhang W, Khoukaz T, Roussos Torres E, Seeber A, Abraham JP, Lou E, Philip PA, Weinberg BA, Shields AF, Goldberg RM, Marshall JL, Venook AP, Korn WM, Lenz HJ. Battaglin F, et al. Among authors: mumenthaler sm. J Immunother Cancer. 2024 Jan 11;12(1):e007939. doi: 10.1136/jitc-2023-007939. J Immunother Cancer. 2024. PMID: 38212126 Free PMC article.
Immunogenic cell death pathway polymorphisms for predicting oxaliplatin efficacy in metastatic colorectal cancer.
Arai H, Xiao Y, Loupakis F, Kawanishi N, Wang J, Battaglin F, Soni S, Zhang W, Mancao C, Salhia B, Mumenthaler SM, Weisenberger DJ, Liang G, Cremolini C, Falcone A, Millstein J, Lenz HJ. Arai H, et al. Among authors: mumenthaler sm. J Immunother Cancer. 2020 Nov;8(2):e001714. doi: 10.1136/jitc-2020-001714. J Immunother Cancer. 2020. PMID: 33172883 Free PMC article.
AMPK variant, a candidate of novel predictor for chemotherapy in metastatic colorectal cancer: A meta-analysis using TRIBE, MAVERICC and FIRE3.
Tokunaga R, Cao S, Naseem M, Battaglin F, Lo JH, Arai H, Loupakis F, Stintzing S, Puccini A, Berger MD, Soni S, Zhang W, Mancao C, Salhia B, Mumenthaler SM, Weisenberger DJ, Liang G, Cremolini C, Heinemann V, Falcone A, Millstein J, Lenz HJ. Tokunaga R, et al. Among authors: mumenthaler sm. Int J Cancer. 2019 Oct 15;145(8):2082-2090. doi: 10.1002/ijc.32261. Epub 2019 Mar 26. Int J Cancer. 2019. PMID: 30856283 Free PMC article.
RNA-Binding Protein Polymorphisms as Novel Biomarkers to Predict Outcomes of Metastatic Colorectal Cancer: A Meta-analysis from TRIBE, FIRE-3, and MAVERICC.
Arai H, Cao S, Battaglin F, Wang J, Kawanishi N, Tokunaga R, Loupakis F, Stintzing S, Soni S, Zhang W, Mancao C, Salhia B, Mumenthaler SM, Cremolini C, Heinemann V, Falcone A, Millstein J, Lenz HJ. Arai H, et al. Among authors: mumenthaler sm. Mol Cancer Ther. 2021 Jun;20(6):1153-1160. doi: 10.1158/1535-7163.MCT-20-0649. Epub 2021 Mar 30. Mol Cancer Ther. 2021. PMID: 33785650
Germ line polymorphisms of genes involved in pluripotency transcription factors predict efficacy of cetuximab in metastatic colorectal cancer.
Arai H, Millstein J, Loupakis F, Stintzing S, Wang J, Battaglin F, Kawanishi N, Jayachandran P, Soni S, Zhang W, Mumenthaler SM, Cremolini C, Heinemann V, Falcone A, Lenz HJ. Arai H, et al. Among authors: mumenthaler sm. Eur J Cancer. 2021 Jun;150:133-142. doi: 10.1016/j.ejca.2021.03.048. Epub 2021 Apr 23. Eur J Cancer. 2021. PMID: 33901792
Germline polymorphisms in genes maintaining the replication fork predict the efficacy of oxaliplatin and irinotecan in patients with metastatic colorectal cancer.
Arai H, Xiao Y, Millstein J, Wang J, Battaglin F, Kawanishi N, Jayachandran P, Soni S, Zhang W, Mancao C, Salhia B, Mumenthaler SM, Parikh AR, Lenz HJ. Arai H, et al. Among authors: mumenthaler sm. Br J Cancer. 2022 Jan;126(1):72-78. doi: 10.1038/s41416-021-01592-7. Epub 2021 Oct 23. Br J Cancer. 2022. PMID: 34689170 Free PMC article. Clinical Trial.
Neurotransmitter signaling: a new frontier in colorectal cancer biology and treatment.
Battaglin F, Jayachandran P, Strelez C, Lenz A, Algaze S, Soni S, Lo JH, Yang Y, Millstein J, Zhang W, Roussos Torres ET, Shih JC, Mumenthaler SM, Neman J, Lenz HJ. Battaglin F, et al. Among authors: mumenthaler sm. Oncogene. 2022 Oct;41(43):4769-4778. doi: 10.1038/s41388-022-02479-4. Epub 2022 Oct 1. Oncogene. 2022. PMID: 36182970 Free PMC article. Review.
Breast cancer and neurotransmitters: emerging insights on mechanisms and therapeutic directions.
Jayachandran P, Battaglin F, Strelez C, Lenz A, Algaze S, Soni S, Lo JH, Yang Y, Millstein J, Zhang W, Shih JC, Lu J, Mumenthaler SM, Spicer D, Neman J, Roussos Torres ET, Lenz HJ. Jayachandran P, et al. Among authors: mumenthaler sm. Oncogene. 2023 Feb;42(9):627-637. doi: 10.1038/s41388-022-02584-4. Epub 2023 Jan 18. Oncogene. 2023. PMID: 36650218 Free PMC article. Review.
Impact of polymorphisms within genes involved in regulating DNA methylation in patients with metastatic colorectal cancer enrolled in three independent, randomised, open-label clinical trials: a meta-analysis from TRIBE, MAVERICC and FIRE-3.
Puccini A, Loupakis F, Stintzing S, Cao S, Battaglin F, Togunaka R, Naseem M, Berger MD, Soni S, Zhang W, Mancao C, Salhia B, Mumenthaler SM, Weisenberger DJ, Liang G, Cremolini C, Heinemann V, Falcone A, Millstein J, Lenz HJ. Puccini A, et al. Among authors: mumenthaler sm. Eur J Cancer. 2019 Apr;111:138-147. doi: 10.1016/j.ejca.2019.01.105. Epub 2019 Mar 7. Eur J Cancer. 2019. PMID: 30852420 Free PMC article.
Clocking cancer: the circadian clock as a target in cancer therapy.
Battaglin F, Chan P, Pan Y, Soni S, Qu M, Spiller ER, Castanon S, Roussos Torres ET, Mumenthaler SM, Kay SA, Lenz HJ. Battaglin F, et al. Among authors: mumenthaler sm. Oncogene. 2021 May;40(18):3187-3200. doi: 10.1038/s41388-021-01778-6. Epub 2021 Apr 12. Oncogene. 2021. PMID: 33846572 Free PMC article. Review.
55 results